Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Endonovo Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Endonovo Therapeutics Price Performance
Endonovo Therapeutics Company Profile
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Further Reading
- Five stocks we like better than Endonovo Therapeutics
- Overbought Stocks Explained: Should You Trade Them?
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- How to Invest in the Best Canadian Stocks
- Is American Express the Credit Stock For a K-Shaped Economy?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
